Phase 2 trial of eritoran tetrasodium (E5564), a Toll-like receptor 4 antagonist, in patients with severe sepsis*Mark Tidswell, Steven M. Opal, Melvyn Lynn et al.|Critical Care Medicine|2009Cited by 226